StockData
Northwest Biotherapeutics Inc logo

Northwest Biotherapeutics Inc (NWBO) stock

NWBOOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.16−0.00 (-0.88%)

Close on Oct 19, 2026Market cap $254.79MP/E –Yield –

Northwest Biotherapeutics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Northwest Biotherapeutics's operating cash flow for the twelve months ending Jun 30, 2026 was -$48.34M. For fiscal 2025 it was -$44.76M. The highest annual figure on record is -$6.38M in fiscal 2010.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$44.76M–
FY2024Dec 31, 2024-$57.02M–
FY2023Dec 31, 2023-$53.64M–
FY2022Dec 31, 2022-$52.78M–
FY2021Dec 31, 2021-$38.30M–
FY2020Dec 31, 2020-$32.09M–
FY2019Dec 31, 2019-$31.86M–
FY2018Dec 31, 2018-$34.59M–
FY2017Dec 31, 2017-$36.50M–
FY2016Dec 31, 2016-$55.65M–
FY2015Dec 31, 2015-$79.71M–
FY2014Dec 31, 2014-$54.58M–
FY2013Dec 31, 2013-$37.80M–
FY2012Dec 31, 2012-$22.75M–
FY2011Dec 31, 2011-$14.71M–
FY2010Dec 31, 2010-$6.38M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$7.17M–
Q1 FY2026Mar 31, 2026-$12.51M–
Q4 FY2025Dec 31, 2025-$14.76M–
Q3 FY2025Sep 30, 2025-$13.89M–
Q2 FY2025Jun 30, 2025-$6.69M–
Q1 FY2025Mar 31, 2025-$9.42M–
Q4 FY2024Dec 31, 2024-$20.18M–
Q3 FY2024Sep 30, 2024-$8.23M–
Q2 FY2024Jun 30, 2024-$16.20M–
Q1 FY2024Mar 31, 2024-$12.41M–
Q4 FY2023Dec 31, 2023-$16.96M–
Q3 FY2023Sep 30, 2023-$13.92M–
Q2 FY2023Jun 30, 2023-$11.52M–
Q1 FY2023Mar 31, 2023-$11.24M–
Q4 FY2022Dec 31, 2022-$8.85M–
Q3 FY2022Sep 30, 2022-$16.12M–
Q2 FY2022Jun 30, 2022-$14.84M–
Q1 FY2022Mar 31, 2022-$12.97M–
Q4 FY2021Dec 31, 2021-$11.25M–
Q3 FY2021Sep 30, 2021-$7.01M–
Q4 FY2020Dec 31, 2020-$10.20M–
Q3 FY2020Sep 30, 2020-$8.02M–
Q2 FY2020Jun 30, 2020-$6.33M–
Q1 FY2020Mar 31, 2020-$7.54M–
Q4 FY2019Dec 31, 2019-$5.98M–
Q3 FY2019Sep 30, 2019-$6.45M–
Q2 FY2019Jun 30, 2019-$9.68M–
Q1 FY2019Mar 31, 2019-$9.75M–
Q4 FY2018Dec 31, 2018-$14.18M–
Q3 FY2018Sep 30, 2018-$4.05M–
Q2 FY2018Jun 30, 2018-$11.57M-218.0%
Q1 FY2018Mar 31, 2018-$4.79M–
Q4 FY2017Dec 31, 2017-$14.79M–
Q4 FY2016Dec 31, 2016-$14.10M–
Q3 FY2016Sep 30, 2016$9.80M–
Q2 FY2016Jun 30, 2016-$14.21M–
Q1 FY2016Mar 31, 2016-$17.60M–
Q4 FY2015Dec 31, 2015-$23.23M–

More Northwest Biotherapeutics figures

See a number that looks wrong?